Full Text (PDF)
Pediatric Education and Research 13((Special Supplement -I)):p 229-232, July-December 2025. | DOI: 10.21088/per.2321.1644.13225.46
Review Article
Contribution of Dr. Vincent J. Freda in Field of Pediatrics
Poorvi Pareek, Kasumbiwal Ajay H, Lakhe Siddheshwar A, Mundhe Sudarshan R
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator
Pediatric Education and Research 13((Special Supplement -I)):p 229-232, July-December 2025. | DOI: 10.21088/per.2321.1644.13225.46
How Cite This Article:
Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R., et al. Contribution of Dr. Vincent J. Freda in Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 229-232.Timeline
Received : December 11, 2025
Accepted : December 28, 2025
Published : December 30, 2025
Abstract
This article examines the life and enduring scientific legacy of Dr. Vincent J. Freda (1928–2018), a pioneering American obstetrician and researcher. Freda is primarily recognized for his pivotal role in developing Rh immune globulin (RhoGAM), a revolutionary treatment that transformed perinatal and pediatric medicine. Prior to his work, Rh hemolytic disease of the newborn (erythroblastosis fetalis) was a devastating and often fatal condition in infants. Freda, in collaboration with his colleagues, conceived and proved the theory of passive immunization, demonstrating that administering anti-Rh antibodies to Rhnegative mothers could prevent their immune systems from forming permanent, harmful antibodies against Rh-positive fetal blood. This intervention effectively made Rh disease a preventable condition. The article details Freda’s background, the ethical and scientific struggles he overcame during the clinical trials, and the monumental impact of RhoGAM, which led to a dramatic global decline in the incidence of the disease. His journey serves as a powerful testament to the value of dedicated research, interdisciplinary teamwork, and the ethical pursuit of humanitarian solutions in medicine. Key Messages: Dr. Vincent J. Freda revolutionized perinatology by developing Rh immune globulin (RhoGAM). This discovery, rooted in collaborative research and perseverance, transformed a common, fatal Rh blood disease in newborns into a preventable condition, saving millions of lives.
References
- 1. Bowman, J.M. (2006). A short history of Rh prophylaxis. Transfusion Medicine Reviews, 20(1), 59-69.
- 2. Freda, V.J., Gorman, J.G., & Pollack, W. (1966). Rh factor: Prevention of immunization and treatment of the immunized patient. The American Journal of Obstetrics and Gynecology, 95(1), 127- 133.
- 3. Zimmerman, D.R. (1973) Rh: The intimate history of a disease and its conquest. MacMillan
- 4. Wen, S.W., & Fraser, W.D. (2009). The Rh immunoglobulin. In seminars in Perinatology, 33(2) 104 - 112. W.B. Saunders.
- 5. Gorman, J.G. (2012). The story of Rh immunoglobulin. Vox Sanguinis, 102 (4), 282 - 289
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
The authors report no conflicts of interest in this work.
About this article
Cite this article
Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan R., et al. Contribution of Dr. Vincent J. Freda in Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 229-232.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator
| Received | Accepted | Published |
|---|---|---|
| December 11, 2025 | December 28, 2025 | December 30, 2025 |
DOI: 10.21088/per.2321.1644.13225.46
Keywords
RhoGAMImmunologyRh Disease (Erythroblastosis fetalis)Passive immunizationSearch for Similar Articles
Similar Articles
- Contribution of Dr. Leo Kanner in Field of Pediatrics
- Dr. Marilyn C. Augustyn, MD and Her Contribution to ADHD
- Contribution of Sir Anton Ghon in the Field of Paediatrics
- Dr. Peter H. Wolff: Foundational Contributions to Infant Development in Pediatri...
- The Contribution of Harvey Cushing in Pediatrics
Article Level Metrics
Last UpdatedSunday 21 June 2026, 18:12:47 (IST)
625
Accesses
4
110
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | December 11, 2025 |
| Accepted | December 28, 2025 |
| Published | December 30, 2025 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator
